Campus IFOM-IEO

More to explore

Research and competitiveness

More research and better research, but also more competitiveness at the international level.

With these ambitious goals in mind, IFOM and IEO have set out to integrate their scientific activities. The 22.000 square meter IFOM-IEO Campus was inaugurated in 2007; it hosts both the research activities and the technical facilities of the two Institutes.

At full capacity, the Campus will accommodate some 600 scientists belonging to 30 research groups, investigating the most advanced frontiers of cancer-related research, with a marked focus on the transferability of research from the bench to the bedside.

A scientific-technological cluster

The basic idea behind the Campus is to create an active scientific-technological cluster, headed by IFOM and IEO, where eminent experts take part in the scientific training and technology transfer process.

Both the University of Milan and the European School of Molecular Medicine (SEMM) are deeply involved in the training programs.

ifom-ieo campus In the technology transfer sector, and thanks to Genextra (a holding company which is active in the pharmacogenomics and biotechnology fields), the Campus has already given the kick-off to two start-up companies, Congenia and Dac, whose mission is the identification and development of novel anti-tumor drugs as well as other drugs against aging-related cell degeneration pathologies. The Campus is also home to Biopolo, a non-profit company involved in technology transfer and in establishing factual cooperation with Industry.

The technological infrastructure of the cluster is represented by the "Cogentech", Consortium for Genomic Technologies, which manages and coordinates several facilities such as DNA sequencing, Nanotechnologies, Molecular Pathology, Immunology, Protein Analysis, Model Organisms, Imaging and Bioinformatics.